Is it acceptable to give the measles, mumps, and rubella (MMR) vaccine and then administer the Pentacel (DTaP‑Hib‑IPV) vaccine two weeks later?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MMR and Pentacel Spacing: Two Weeks is NOT Recommended

You should NOT give MMR and then Pentacel two weeks later—these vaccines should either be given on the same day at different anatomic sites, or separated by at least 4 weeks. 1

The Core Principle: Live Vaccine Spacing Rules

The critical issue here is that MMR is a live vaccine, and ACIP guidelines are explicit about timing when live vaccines are not given simultaneously:

  • Live vaccines can be given on the same day at different injection sites with no concerns 1
  • If not given on the same day, live vaccines must be separated by ≥4 weeks from other live vaccines 1, 2
  • Inactivated vaccines (like Pentacel) have no minimum interval with live or other inactivated vaccines 2

Why This Matters

The 4-week separation rule for live vaccines exists because giving a second live vaccine too soon after the first may result in immune interference—the first vaccine's immune response could potentially blunt the response to the second live vaccine. However, Pentacel is an inactivated vaccine (DTaP-IPV/Hib), so theoretically it shouldn't interfere with MMR's immune response.

The Practical Answer

Here's what you should do:

  1. Best option: Give both vaccines on the same day at different anatomic sites. This is explicitly supported by guidelines and research showing no safety concerns or immune interference when MMR is co-administered with DTaP-containing vaccines 1, 3, 4

  2. If you must separate them: Wait the full 4 weeks after MMR before giving Pentacel, even though Pentacel is inactivated. While the guideline's 4-week rule technically applies to spacing between two live vaccines, giving an inactivated vaccine at 2 weeks creates an off-schedule situation without clear guidance

  3. Alternative consideration: You could give Pentacel first, then MMR at any interval (even 2 weeks later), since the restriction is on giving a live vaccine after another live vaccine, not on giving an inactivated vaccine before a live one 2

Evidence Supporting Same-Day Administration

Multiple studies demonstrate that MMR and DTaP-containing vaccines can be safely co-administered:

  • A 2019 study showed MMR (Priorix) given with DTaP-IPV demonstrated similar immunogenicity and safety profiles whether given alone or together 3
  • Pentacel specifically has been studied with MMR at 15 months showing no interference with immune responses 4
  • The FDA label for Pentacel and related vaccines confirms compatibility with concomitant MMR administration 5

Common Pitfall to Avoid

Don't confuse the live vaccine spacing rule with general vaccine spacing. The 4-week rule is specifically about live-to-live vaccine interference. However, in practice, when vaccines aren't given according to the recommended schedule, it's safest to either give them together or follow the most conservative spacing guidelines to avoid any potential issues with vaccine series completion and documentation.

Bottom line: Schedule both vaccines for the same visit, or wait 4 weeks. The 2-week interval you're asking about falls into a gray zone that's not supported by guidelines and creates unnecessary scheduling complexity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.